Chemokines and chemokine receptors in inflammatory bowel disease: recent findings and future perspectives

2021 ◽  
Author(s):  
Miguel Camba-Gómez ◽  
Laura Arosa ◽  
Oreste Gualillo ◽  
Javier Conde-Aranda
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Chemokine Receptors ◽  
Future Perspectives ◽  
Inflammatory Bowel

scholarly journals Personalising medicine in inflammatory bowel disease—current and future perspectives

2019 ◽  
Vol 8 (1) ◽  
pp. 56-69 ◽  
Author(s):  
James J. Ashton ◽  
Enrico Mossotto ◽  
Sarah Ennis ◽  
R. Mark Beattie
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Future Perspectives ◽  
Inflammatory Bowel

scholarly journals Oxidative Stress and Antioxidant Nanotherapeutic Approaches for Inflammatory Bowel Disease

Biomedicines ◽  
2021 ◽  
Vol 10 (1) ◽  
pp. 85
Author(s):  
Ping Liu ◽  
Yixuan Li ◽  
Ran Wang ◽  
Fazheng Ren ◽  
Xiaoyu Wang
Keyword(s):  
Oxidative Stress ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Therapeutic Option ◽  
Oxidant Stress ◽  
Reactive Species ◽  
Future Perspectives ◽  
Inflammatory Bowel ◽  
Novel Strategy

Oxidative stress, caused by the accumulation of reactive species, is associated with the initiation and progress of inflammatory bowel disease (IBD). The investigation of antioxidants to target overexpressed reactive species and modulate oxidant stress pathways becomes an important therapeutic option. Nowadays, antioxidative nanotechnology has emerged as a novel strategy. The nanocarriers have shown many advantages in comparison with conventional antioxidants, owing to their on-site accumulation, stability of antioxidants, and most importantly, intrinsic multiple reactive species scavenging or catalyzing properties. This review concludes an up-to-date summary of IBD nanomedicines according to the classification of the delivered antioxidants. Moreover, the concerns and future perspectives in this study field are also discussed.

Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives

2022 ◽  
Vol 7 (2) ◽  
pp. 171-185
Author(s):  
Konstantinos Papamichael ◽  
Waqqas Afif ◽  
David Drobne ◽  
Marla C Dubinsky ◽  
Marc Ferrante ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Therapeutic Drug Monitoring ◽  
Bowel Disease ◽  
Drug Monitoring ◽  
Unmet Needs ◽  
Therapeutic Drug ◽  
Future Perspectives ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document